1.Extendicare
EXE.TO (TSX)
Extendicare stands out as a major long-term care provider in Canada, currently boasting a market cap of CA$2.32 billion. With a solid dividend yield of 1.90% and impressive returns of 108.26% over the past year and 270.86% over five years, this stock offers an attractive option for investors seeking consistent income from a financially healthy company. Analysts maintain a "Hold" rating, indicating a stable outlook amidst its growth potential.
Pros:
- Strong 1-year and 5-year returns
- Major long-term care provider
Cons:
- Market volatility risk
- Dependence on healthcare regulations
2.WELL Health Technologies
WELL.TO (TSX)
WELL Health Technologies stands out as a leading player in digital healthcare, boasting Canada's largest outpatient clinic network. Despite a challenging year with a 1-year return of -21.36% and a 5-year return of -49.71%, the company has shown impressive revenue growth of 56% year-over-year in Q3 2025. With strong analyst ratings, including a "Perform" from Scotiabank, there's still a potential upside of 85% by 2026, making it a noteworthy consideration for investors looking for recovery opportunities in the healthcare sector.
Pros:
- Strong revenue growth (56% y/y in Q3 2025)
- Analyst buy ratings
Cons:
- Negative 1-year return
- High market volatility risk
3.Knight Therapeutics
GUD.TO (TSX)
Knight Therapeutics is a standout specialty pharmaceutical company that strategically acquires branded medicines in Canada and Latin America. Recognized as a top Canadian healthcare stock, it has delivered impressive returns of 13.27% over the past year and 24.10% over the last five years, positioning itself well despite facing challenges in profitability with increasing losses. Recent ratings from Raymond James indicate an "Outperform" outlook, suggesting that investors may want to keep an eye on this company's growth potential in the healthcare sector.
Pros:
- Solid market position
- Recognized as a top Canadian healthcare stock
Cons:
- Unprofitable over the last year
- Increased losses over the past 5 years
Final Words
As you consider your investment options in healthcare stocks this March 2026, remember to evaluate the potential of companies like WELL Health Technologies, which shows promising growth. Take time to compare these opportunities and conduct your own research to make informed decisions that align with your financial goals.
Frequently Asked Questions
WELL Health Technologies is recognized for its significant revenue growth of 56% year-over-year in Q3 2025 and is noted for having a strong analyst buy rating. Additionally, the company has an impressive upside potential of 85% into 2026.
As of now, WELL Health Technologies has a current price of $4.27 and a market cap of $1.08 billion. The stock has shown a year-to-date return of 5.43%, despite a 1-year return of -21.36%.
WELL Health Technologies provides a wide range of healthcare services, including primary care, physiotherapy, mental health counseling, and telehealth services. They also offer specialized care and diagnostic services across various health fields.
Investing in healthcare stocks can involve risks such as regulatory changes, market volatility, and competition within the industry. It’s essential to conduct thorough research and consider the company's performance history before investing.
To evaluate healthcare stocks, consider factors such as revenue growth, market position, analyst ratings, and financial health. Additionally, analyzing the company’s service offerings and industry trends can provide further insights into its potential.
WELL Health Technologies has demonstrated significant long-term potential with a max return of 2950.00% over its history. However, prospective investors should consider their financial goals and the inherent risks in the healthcare sector before making a commitment.
